SELLAS Life Sciences is rated Hold, with a $9.25 price target, as the current valuation reflects REGAL trial success ...

Dual recognition in 2026 Frost Radar™ reports marks a fourth consecutive year of Frost Radar leadership for LabVantage.

Caris Life Sciences' Q2 featured accelerating clinical volumes, 68% gross margin, and strong early traction for Caris Detect.

Plus: Billionaires push psychedelic treatments; investor Agora makes first deal ...

Buoyed by the rapid development of COVID-19 vaccines, the life sciences industry is on track for a succession of upheavals already transforming patient care, business models, and market dynamics. In ...

As costs and regulatory pressures rise and educated patients clamor for personalized treatment, digital innovations will inexorably alter the life sciences landscape. Michael Townsend, research ...

A ccording to the CBRE U.S. Life Sciences Outlook 2025 report, U.S life sciences employment hit a record high in 2024, and more job growth is expected in 2025. Meanwhile, the life sciences sector ...

Rubedo Life Sciences, Inc. (Rubedo) today announced a new clinical study of investigational RLS-1496 in patients with ...

BioAlberta is honoured to announce the recipients of the 2026 Achievement Awards at the Health and Life Sciences Showcase and Awards Dinner in Calgary on September 24 th, 2026. This year’s award ...

CND Life Sciences, Inc. (CND), a medical technology company that advances neurodiagnostic tests and associated biomarker ...

The companies that successfully raise money increasingly aren’t just those with the best research or technology. They are ...

Sep. 17 Tiziana Life Sciences Ltd Announces Signing of Memorandum of Understanding with King Abdullah International Medical Research Center and Foundation for Neurologic Diseases CI Sep. 03 BTIG ...